Literature DB >> 15304507

The human TAZ gene complements mitochondrial dysfunction in the yeast taz1Delta mutant. Implications for Barth syndrome.

Lining Ma1, Frederic M Vaz, Zhiming Gu, Ronald J A Wanders, Miriam L Greenberg.   

Abstract

Barth syndrome is a genetic disorder that is caused by different mutations in the TAZ gene G4.5. The yeast gene TAZ1 is highly homologous to human TAZ, and the taz1Delta mutant has phospholipid defects similar to those observed in Barth syndrome cells, including aberrant cardiolipin species and decreased cardiolipin levels. Subcellular fractionation studies revealed that Taz1p is localized exclusively in mitochondria, which supports the theory that tafazzins are involved in cardiolipin remodeling. Because cardiolipin plays an important role in respiratory function, we measured the energy transformation and osmotic properties of isolated mitochondria from the taz1Delta mutant. Energy coupling in taz1Delta mitochondria was dependent on the rate of oxidative phosphorylation, as coupling was diminished when NADH was used as a respiratory substrate but was unaffected when ethanol was the substrate. Membrane stability was compromised in taz1Delta mitochondria exposed to increased temperature and hypotonic conditions. Mitochondria from taz1Delta also displayed decreased swelling in response to ATP, which induces the yeast mitochondrial unspecific channel, and to alamethicin, a membrane-disrupting agent. Coupling was measured in taz1Delta cells containing different splice variants of the human TAZ gene. Only the variant that restores wild type cardiolipin synthesis (lacking exon 5) restored coupling in hypotonic conditions and at elevated temperature. These findings may shed light on the mitochondrial deficiencies observed in Barth syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304507     DOI: 10.1074/jbc.M405479200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography.

Authors:  Devrim Acehan; Yang Xu; David L Stokes; Michael Schlame
Journal:  Lab Invest       Date:  2006-10-16       Impact factor: 5.662

Review 2.  Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes.

Authors:  Michael Schlame
Journal:  J Lipid Res       Date:  2007-12-12       Impact factor: 5.922

Review 3.  Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function.

Authors:  Steven M Claypool
Journal:  Biochim Biophys Acta       Date:  2009-05-05

4.  Cardiolipin affects the supramolecular organization of ATP synthase in mitochondria.

Authors:  Devrim Acehan; Ashim Malhotra; Yang Xu; Mindong Ren; David L Stokes; Michael Schlame
Journal:  Biophys J       Date:  2011-05-04       Impact factor: 4.033

Review 5.  Mitochondrial dysfunctions in barth syndrome.

Authors:  Sagnika Ghosh; Donna M Iadarola; Writoban Basu Ball; Vishal M Gohil
Journal:  IUBMB Life       Date:  2019-02-11       Impact factor: 3.885

Review 6.  Cardiolipin signaling mechanisms: collapse of asymmetry and oxidation.

Authors:  Valerian E Kagan; Yulia Y Tyurina; Vladimir A Tyurin; Dariush Mohammadyani; Jose Pedro Friedmann Angeli; Sergei V Baranov; Judith Klein-Seetharaman; Robert M Friedlander; Rama K Mallampalli; Marcus Conrad; Hülya Bayir
Journal:  Antioxid Redox Signal       Date:  2015-03-31       Impact factor: 8.401

7.  Specific degradation of phosphatidylglycerol is necessary for proper mitochondrial morphology and function.

Authors:  Lucia Pokorná; Petra Čermáková; Anton Horváth; Matthew G Baile; Steven M Claypool; Peter Griač; Jan Malínský; Mária Balážová
Journal:  Biochim Biophys Acta       Date:  2015-10-19

8.  Unremodeled and remodeled cardiolipin are functionally indistinguishable in yeast.

Authors:  Matthew G Baile; Murugappan Sathappa; Ya-Wen Lu; Erin Pryce; Kevin Whited; J Michael McCaffery; Xianlin Han; Nathan N Alder; Steven M Claypool
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

9.  Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.

Authors:  Tomohiro Kimura; Atsuko K Kimura; Mindong Ren; Bob Berno; Yang Xu; Michael Schlame; Richard M Epand
Journal:  Biochemistry       Date:  2018-03-30       Impact factor: 3.162

10.  Identification of a cardiolipin-specific phospholipase encoded by the gene CLD1 (YGR110W) in yeast.

Authors:  Andreas Beranek; Gerald Rechberger; Heide Knauer; Heimo Wolinski; Sepp D Kohlwein; Regina Leber
Journal:  J Biol Chem       Date:  2009-02-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.